secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001549084-22-000029
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

EKSO shareholders approve equity plan share increase and all proposals at annual meeting
--------------------------------------------------------------------------------

- Elected six directors; average votes for ~4.2M per nominee, with 2.57M broker non-votes each.
- Approved equity plan amendment raising authorized shares from 1,974,286 to 2,524,286; 3.9M for, 621k against.
- Non-binding say-on-pay approved with 4.24M for, 255k against, 43.6k abstain.
- Ratified WithumSmith+Brown as auditor for FY2022 with 6.99M for, 55.7k against.
- Approximately 7.1M shares voted of 12.8M outstanding, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000029/0001549084-22-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000029/ekso-20220609.htm
  HTML page:      https://secwatch.observer/filing/0001549084-22-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer